Steward Partners Investment Advisory’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$475 Sell
28
-451
-94% -$9.67K ﹤0.01% 4265
2025
Q4
$12.3K Sell
479
-865
-64% -$19.9K ﹤0.01% 3357
2025
Q3
$28.9K Buy
1,344
+1,221
+993% +$27.8K ﹤0.01% 2906
2025
Q2
$2.71K Hold
123
﹤0.01% 3667
2025
Q1
$2.75K Hold
123
﹤0.01% 3568
2024
Q4
$2.12K Sell
123
-127
-51% -$1.97K ﹤0.01% 3618
2024
Q3
$4.19K Buy
+250
New +$6K ﹤0.01% 3247
2022
Q3
Sell
-151
Closed -$4K 3342
2022
Q2
$4K Sell
151
-250
-62% -$8.95K ﹤0.01% 2861
2022
Q1
$21K Sell
401
-808
-67% -$34.6K ﹤0.01% 2342
2021
Q4
$61K Buy
1,209
+374
+45% +$20.9K ﹤0.01% 1812
2021
Q3
$47K Sell
835
-669
-44% -$37K ﹤0.01% 1935
2021
Q2
$89K Buy
1,504
+129
+9% +$7.25K ﹤0.01% 2423
2021
Q1
$61.2K Buy
+1,375
New +$64.2K ﹤0.01% 1879

Other funds holding PGNY

Steward Partners Investment Advisory's PGNY Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its Progyny (PGNY) stake by 94% in Q1 2026, selling an estimated $9.67K and leaving 28 shares worth $475. The position accounts for ﹤0.01% of the portfolio, ranked #4265.

Steward Partners Investment Advisory first reported a position in PGNY in Q1 2021 and has held it in 13 quarters since. The position peaked at $89K in Q2 2021. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Steward Partners Investment Advisory held 28 shares of Progyny worth $475 as of Q1 2026.
  • Steward Partners Investment Advisory sold 451 Progyny shares in Q1 2026, an estimated $9.67K.
  • Progyny made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4265 holding.
  • Steward Partners Investment Advisory first reported a position in Progyny in Q1 2021 and has held it in 13 quarters since.
  • Steward Partners Investment Advisory's Progyny position peaked at $89K in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.